Checked.be
Active
BE 0786.825.891Private limited company
PROTEETH
Rue Sainte-Rita(BU) 112 ·5004 Namur, Belgium· 4 yrs active
Sector: Dental practice
(86230)
Conclusion
PROTEETH has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €613k and a net result of €370k. Equity is growing by ~33.2% per year across the filed fiscal years. Its solvency ranks better than 44% of 16132 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Based on the State Gazette, CBE and 4 annual accounts.
Key figures
| Equity | €613k |
| Net result | €370k |
| Better than sector | 44% |
| Active | 4 yrs |
Financial profile
94
/ 100
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Health
100
Profitability
100
Solvency
97
Growth
78
Stability
94
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2022, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
100
/ 100
Excellent
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€60k
estimate, not credit advice
Score history
85
2022
100
2023
100
2024
100
2025
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 2.13 (≥ 1.5)
+10
Quick ratio
Quick ratio 2.13 (≥ 1.0)
+5
Leverage
Debt/equity 0.79 (< 1.0)
+10
Profitability
ROE 60% (≥ 10%)
+10
Interest coverage
Interest coverage 4006.3× (≥ 3×)
+8
Profit trend
Net profit up YoY
+5
Equity growth
Equity growing YoY
+3
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview
Annual accounts filed on 30-06-2026 with the NBB · fiscal year 2025 · micro schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Equity: growth of ~33.2%/year over 4 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2025 · NACE 86, Human health activities · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 55.9% | 63.4% | |
| Net result | €370k | €62k | |
| Equity | €613k | €132k | |
| Gross operating margin | €503k | €116k | |
| Total assets | €1.10M | €286k |
€501k
+32.8%
22-25
€370k
+33.3%
22-25
€385k
+31.5%
22-25
€1.10M
+53.3%
22-25
€613k
0.0%
22-25
€544k
-5.8%
22-25
€120k
+34.6%
22-25
€370k
-
22-25
€483k
+373.4%
22-25
€483k
+373.4%
22-25
2.13
-68.1%
22-25
2.13
-68.1%
22-25
55.9%
-34.8%
22-25
0.79
+373.4%
22-25
60.4%
+33.3%
22-25
33.8%
-13.0%
22-25
4006.35
+170.0%
22-25
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - |
| EBITDA | €501k | €377k | €231k | €220k |
| Net profit | €370k | €278k | €166k | €165k |
| Cash flow | €385k | €293k | €178k | €169k |
| Staff costs | - | - | - | - |
| Income taxes | €120k | €90k | €52k | €51k |
| Dividends | €370k | - | - | - |
| Total assets | €1.10M | €715k | €395k | €224k |
| Equity | €613k | €613k | €335k | €169k |
| Debt | €483k | €102k | €61k | €56k |
| of which ≤ 1y | €483k | €102k | €61k | €56k |
| of which > 1y | - | - | - | - |
| Working capital | €544k | €578k | €285k | €144k |
| Employees (FTE) | - | - | - | - |
Ratios (computed)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Current ratio | 2.13 | 6.67 | 5.70 | 3.59 |
| Quick ratio | 2.13 | 6.67 | 5.70 | 3.59 |
| Working capital ratio | 49.7% | 80.8% | 72.1% | 64.2% |
| Solvency | 55.9% | 85.7% | 84.7% | 75.2% |
| Debt / equity | 0.79 | 0.17 | 0.18 | 0.33 |
| Long-term debt ratio | - | - | - | - |
| Interest coverage | 4006.35 | 1483.75 | 4393.98 | - |
| Gross margin | - | - | - | - |
| Net margin | - | - | - | - |
| ROA | 33.8% | 38.9% | 42.0% | 73.7% |
| ROE | 60.4% | 45.3% | 49.6% | 98.0% |
| EBITDA margin | - | - | - | - |
| Days sales outstanding | - | - | - | - |
| Days payable outstanding | - | - | - | - |
| Inventory turnover | - | - | - | - |
| Days inventory (DSI) | - | - | - | - |
Balance-sheet composition 2025
Full annual accounts (23 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Balance sheet, Assets | |||||
| TOTAL ASSETS | 20/58 | €1.10M | €715k | €395k | €224k |
| Fixed assets | 21/28 | €69k | €35k | €50k | €25k |
| Tangible fixed assets | 22/27 | €33k | €35k | €50k | €25k |
| Financial fixed assets | 28 | €36k | - | - | - |
| Current assets | 29/58 | €1.03M | €680k | €345k | €200k |
| Amounts receivable within one year | 40/41 | - | - | €3k | €9k |
| Investments | 50/53 | €510k | €36k | €210k | - |
| Cash & bank | 54/58 | €457k | €523k | €50k | €161k |
| Balance sheet, Equity & liabilities | |||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.10M | €715k | €395k | €224k |
| Equity | 10/15 | €613k | €613k | €335k | €169k |
| Contributions / capital | 10/11 | €3k | €3k | €3k | €3k |
| Accumulated profits (losses) | 14 | €609k | €609k | €331k | €165k |
| Amounts payable | 17/49 | €483k | €102k | €61k | €56k |
| Amounts payable within one year | 42/48 | €483k | €102k | €61k | €56k |
| Trade debts payable within one year | 44 | - | €1k | - | €2k |
| Income statement | |||||
| Gross operating margin | 9900 | €503k | €379k | €233k | €222k |
| Operating result | 9901 | €486k | €362k | €218k | €216k |
| Financial income | 75 | €5k | €6k | - | - |
| Financial charges | 65 | €125 | €254 | €53 | - |
| Result before taxes | 9903 | €491k | €367k | €218k | €216k |
| Income taxes | 67/77 | €120k | €90k | €52k | €51k |
| Net result for the period | 9904 | €370k | €278k | €166k | €165k |
| Result to be appropriated | 9905 | €370k | €278k | €166k | €165k |
Legal Structure
| NACE primary | Dental practice(86230) |
| Legal form | Private limited company(610) |
| Incorporation | 03-06-2022 |
| Status | Active |
| Postal code | 5004 |
Establishment units
PROTEETH
since 20222.332.372.918
cabinet riffont
since 20232.347.709.212
Real-estate footprint
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92135B0370/00A000 | Wallonia | 3,109 m² | 1 · 268 m² | 9.2 m · 2 fl. |
| 92021C0160/00X015 | Wallonia | 1,777 m² | 1 · 219 m² | 7.8 m · 1 fl. |
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
Next filing, fiscal year 2026, expected by
2026
30-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2022net €370k ▲33.3%
Operating result €486k, net result €370k, both a record.
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
31-12
Financial
Equity above €500kEq €613k ▲83%
3 profitable years in a row build equity to €613k.
31-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €200kEq €335k ▲98.5%
2 profitable years in a row build equity to €335k.
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
Dental practice86230
Names & trade names
| Legal nameFR | PROTEETH |
Similar companies
TANDARTS EVELYNE VANDENDORPE
BE 0892.608.351 · Zwevegem
TANDARTSPRAKTIJK DE ZAAT
BE 0477.852.187 · Temse
OUDEBROUCKX A. - L.
BE 0832.047.687 · Wellen
Megabite & Co
BE 0634.812.441 · Leuven
DE KEERSMAEKER GEERT
BE 0455.167.847 · Pajottegem